Universities continue to turn down the “Trump Compact”. The intitial nine schools targeted with an “invitation” were from a seemingly curated list of elite institutions, though some are perhaps notably less wealthy or more aspirational than the others. I can’t help but think there was some attempt to create a prisoner’s dilemma situation, where one more eager or fearful university might start a domino effect by committing first. That has not occurred.
What I do expect at some point in the coming weeks is a broadened offering of the compact to schools across the country. I expect messaging that specifically targets large public universities in states with Republican-controlled state legislatures that will be leveraged to pressure schools to sign on to the compact in hopes of currying favor with the administration and their voter base. I expect several schools to sign.
Here’s why I think that would be a grave mistake.
The compact comes with promises of “most-favored” status for applicants to federal grants through institutions such as the NIH, NSF, and Department of Defense. The thing is, they can promise that all they want. They don’t actually have that much influence over the review process. They’ll no doubt work to tip the scales on a few grants and promote them heavily, but the media coverage will vastly outweigh the dollars being shifted by the compact. It will, as always, be theater first and governance last.
But let’s say your school does procure several grants. Perhaps you’re a school that has in the past carried $20 to $30 million in active grants from the NIH and NSF, amounting to roughly $5 million per year in operating expenses. That sounds like a lot, but it’s not. Johns Hopkins University, by comparison, had $843 million in just NIH grants active in 2023. If you’re operating with $5 million a year in grant money, you have an office of sponsored projects, an Internal Review Board for human subjects research, and maybe an office for industry sponsorship. That maybe amounts to 15 to 20 personnel. What happens if the Trump administration comes through, putting its thumb on the scale for you, doubling or tripling your active grants within two years?
Chaos. Institutional chaos.
Sponsored research requires capital, personnel, and resource management. It requires legal compliance, doubly so if you’re spending federal money. It requires experienced leadership and management that know how to check boxes, file reports, track money, review protocols, and continuously train ever-churning research personnel.
But hey, that’s the point, you might be saying. We want to be ambitious and grown, we want to hire new and experienced personnel. We want to grow into an important research institution and this is our big chance! Be careful what you wish for. It’s one thing to incrementally grow over years and decades. It’s a whole other thing to try to do it in reaction to a sudden influx of money. Which, to be clear, isn’t just money. It’s an obligation. An expectation to produce scientific contributions on the US taxpayers’ dime. Obligations come with many things, but patience with incompetence borne of growing pains isn’t one of them.
But none of that is the problem. The real problem. The trap.
The trap is that this money isn’t going to stick around. This regime isn’t permanent. They aren’t invested in any way in scientific public goods or even science as a conept. This is, again, theater. They will move on to other things the instant it fails to the get the traction they want. They will lose elections, political tides will turn, etc. And what your institution will be left with is the reputation you earned.
And what will that reputation be? One of compliance with an anti-science, anti-public health, anti-intellectual regime. Further, you will judged on the fruits of that compliance. At the margin, it will be science that was undersupported, delayed in launch, stalled in execution, and eventually delivered short of expectations. You will have sold your reputation for a ticket on a ride you weren’t tall enough to be on yet. Grants will dry up, returning to previous levels or worse, leaving you with a bloated staff you no longer need, trying to find ways to lay off employees with all the protections of state government labor regulations.
There is no getting rich quick in academic research. There’s only avenues of over-reaching impatience ending in tears.
Economist Writing Every Day 